Skip to main content

Table 5 Age-adjusted, Sex-adjusted and eGFR-adjusted logistic regression analysis, odds ratio (OR) with 95% confidence intervals (CI), of in-hospital mortality in patients with COVID-19

From: “Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19”

 

Age-adjusted

Sex-adjusted

eGFR-adjusted

 

P-value

OR

95% CI

P-value

OR

95% CI

P-value

OR

95% CI

s-Creatinine (µmol/l)

NS

1.001

0.996–1.007

NS

1.001

0.995–1.007

-

-

-

eGFRa (ml/min/1.73m2)

NS

0.983

0.955–1.012

 = 0.010

0.969

0.946–0.993

-

-

-

CRPb (mg/l)

 = 0.01

1.008

1.002–1.015

 = 0.010

1.008

1.002–1.015

 = 0.01

1.008

1.002–1.014

WBCc count (x10i/l)

 = 0.001

1.438

1.167–1.771

 = 0.001

1.341

1.136–1.582

 < 0.01

1.266

1.080–1.484

Neutrophil count (x10i/l)

 < 0.001

1.512

1.189–1.921

 = 0.001

1.423

1.161–1.745

 = 0.001

1.464

1.171–1.832

Lymphocyte count (x10i/l)

NS

1.127

0.342–3.715

NS

0.746

0.251–2.213

NS

1.163

0.375–3.613

NLRd

 < 0.05

1.117

1.009–1.237

 < 0.05

1.119

1.019–1.230

0.058

1.111

0.996–1.239

B cell modulation

 BAFFe (pg/ml)

0.058

1.001

1.000–1.002

 < 0.05

1.001

1.000–1.002

NS

1.001

1.000–1.001

 IL-4f (pg/ml)

NS

1.004

0.995–1.014

NS

1.002

0.994–1.009

NS

1.001

0.992–1.010

 IFN- αg (pg/ml)

NS

1.004

0.995–1.013

NS

1.002

0.994–1.010

NS

1.005

0.999–1.010

T cell modulation

 sCD25h/IL-2Rαi (pg/ml)

 < 0.05

1.000

1.000–1.001

 < 0.05

1.000

1.000–1.001

NS

1.000

1.000–1.001

 sCD40L (pg/ml)

NS

1.000

0.999–1.001

NS

1.000

0.999–1.001

NS

1.000

0.999–1.001

 sPD-L1j (pg/ml)

NS

1.003

0.999–1.008

 < 0.05

1.004

1.000–1.009

NS

1.002

0.997–1.007

 sCD95 (pg/ml)

NS

1.000

1.000–1.000

NS

1.000

1.000–1.000

NS

1.000

1.000–1.000

  1. a Estimated glomerular filtration rate
  2. b C-reactive protein
  3. c White blood cells
  4. d Neutrophil-leukocyte ratio
  5. e B-cell activating factor
  6. f Interleukin 4
  7. g Interferon-α
  8. h Soluble cluster of differentiation 25
  9. i Interleukin 2 receptor- α
  10. j Soluble programmed death-ligand 1